WHO Issues Warning Over Critical Scarcity of Weight-Loss Medications
Less than a tenth of individuals eligible to benefit from GLP-1 drugs such as Wegovy are able to get them, caution the global health agency as it publishes its initial recommendations on the medications.
Considering in excess of 1,000,000,000 individuals worldwide currently obese, it is calling for broader and more equitable availability to GLP-1 medication.
Based on projections, more than two billion will be living with obesity by 2030 without intervention.
"Our new guidance recognises that obesity is a long-term condition that can be treated with thorough and ongoing support," remarked WHO director-general Tedros Adhanom Ghebreyesus.
Significant expense, limited production capacity, and supply-chain constraints are key barriers to universal availability to the injections that can assist patients in reducing significant body mass, explains the body.
Weight-Loss Drug Scarcity
Despite the current most optimistic outlook, the production of such drugs might only reach approximately 100 million people – under 10% of the global need, as stated by the health organization.
The advice calls on nations and manufacturers to expand access, through approaches including licensing agreements.
Exclusive production rights on a key compound – the primary component of a leading brand – is scheduled to end in multiple nations in 2026.
The Way Weight-Loss Drugs Work
The injections mimick a natural hormone to reduce digestion speed, suppress the appetite and enhance the sense of being full so people reduce food intake.
Patients commonly see weight reduction after several weeks of commencing the regular doses.
Studies suggests users may see weight return a year later of stopping the drug, as their typical appetite resume.
To be overweight or obese elevates your risk for experiencing health problems, such as type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.
Obesity concerns people in every country and was responsible for millions of deaths worldwide in 2024, according to the WHO.
